SpringWorks Therapeutics (SWTX) Earnings Date & Reports
Get AI intraday signals
A.I. Advisor
published Earnings
SWTX is expected to report earnings to fall 11.04% to -64 cents per share on March 04
Q4'24
Est.
$-0.64
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.58
Q1'24
Missed
by $0.01
Q4'23
Missed
by $0.20
The last earnings report on November 12 showed earnings per share of -72 cents, beating the estimate of -75 cents. With 63.87K shares outstanding, the current market capitalization sits at 2.81B.
a clinical-stage biopharmaceutical company, which focuses on developing drugs for underserved patient populations suffering from devastating rare diseases and cancer